AHCO - AdaptHealth reports Q4 earnings miss; initiates FY23 outlook

• AdaptHealth press release ( NASDAQ: AHCO ): Q4 GAAP EPS of -$0.02 misses by $0.29 .
• Revenue of $780.3M (+11.1% Y/Y) misses by $7.83M .
• Adjusted EBITDA was $146.0 million, compared to $158.1 million in the fourth quarter of 2021, a decrease of 7.7%.
• Cash flow from operations was $96.9 million, compared to $100.9 million in the fourth quarter of 2021.
• Guidance Updated for Fiscal Year 2023 : The Company is updating its initial financial guidance for fiscal year 2023, as follows: Net revenue of $3.160 billion to $3.240 billion (previously $3.210 billion to $3.290 billion) vs. consensus of $3.26B.
• Adjusted EBITDA of $650 million to $710 million (previously $690 million to $750 million).
• Total capital expenditures representing 10-12% of net revenue (previously 9-11% of net revenue).

For further details see: